for many laboratories and facilitate quantitation of cellular properties on an objective basis. We have sought to apply these advances across a range of prokaryotic applications and here we describe the methods we have applied to live
Not CAR-T / NK / M, new cell therapy technology is coming, the goal is to conquer solid tumors!
Time of Update: 2021-01-31
January 6, his new company, Myeloid Therapeutics, launched for more than $50 million, with Newpath Partners, 8VC and others to launch clinical trials on T-cell lymphoma, glioblastoma and other solid tumors, as well as further development of myeloid therapy.
STTT: The new coronavirus M protein inhibits the activation of type I and III interferon to achieve immune escape
Time of Update: 2021-01-12
, and TBK1 protein complexes, thereby inhibiting phosphorylation, nucleation, and transcription activation induced by type I and III interferons. this study expounds the important mechanism of SARS-CoV-2 to suppress human antiviral immunity, provides
Land money (M archantia Polymorpha)
Time of Update: 2021-01-09
The characteristics of the earth money are leafy flat, ribbon-like, multi-back branches, light green or dark green, about 1 cm wide, up to 10 cm long, slightly waveged edges, more interwoven into pieces of growth.
Dr. Li Na of the Institute of Tropical Medicine of Hainan Medical College revealed a new mechanism for alleviating food allergies with short Bifidobacteria M-16V
Time of Update: 2020-12-12
become a serious public health problem endangering the health of adults and children. Due to the repeated symptoms of food allergies, and at this stage there is no complete cure, seriously reduce the quality of life of patients, to the family
The National Standard Study of Rat Source (M-MLV) Reverse Transcriptase and Bst Polymerase was completed.
Time of Update: 2020-09-05
reverse transcriptase and Bst polymerase national standard research" basically completed and in the National Standards Commission to form a draft for comments. It is learned that the purpose of this study is to establish two tool enzyme product
JCEM: Lipoprotein M and Type 2 Diabetes Risk
Time of Update: 2020-07-13
Recent studies have found that lipoprotein M (apoM) plays a role in energy metabolism, and observational analysis of the human body suggests that it is related to type 2 diabetes , but the causal relationship is still
AP-T: Serotonin M levels at baseline can predict mucosal healing in Crohn's patients treated with infembite
Time of Update: 2020-07-10
Compared with fecal calcin, the predictive power of anti-cancer M at baseline is considerable, thus indicating that serotonin M is a promising biomarker to drive Crohn's disease treatment options.
Merck opens largest M Lab collaboration center in Shanghai
Time of Update: 2020-07-10
the new M Lab ™ Collaboration Center in Shanghai provides customized solutions specifically designed for the life sciences sector in China to help advance drug development.
Gastroenterology: Vitolic acid and lymphocytoxsignalation can promote differentiation of human intestinal M cells
Time of Update: 2020-06-22
conclusion: This study identified the signaling pathways needed for intestinal M cell differentiation and used this information to create a powerful culture method for developing human M cells with viral internalization and transport capabilities.
Y-m Abs announces positive data for naxitamab and GM-CSF joint clinical trial
Time of Update: 2020-06-07
recently, Y-mAbs ( announced that its humanized monoclonal antibody naxitamab, a humanoid monoclonal antibody to GD2 antigens, was combined with GM-CSF to obtain positive efficacy
CDC20-M Suggests Genomic Instability in Glioma
Time of Update: 2020-06-03
Yunqiu Zhang of the Neuroscience and Brain Development Laboratory at Beijing Normal University found that CDC20 co-expression gene module (CDC20-M) significantly improved expression in glioma, which is associated with glioma GI; The findings were published in PNAS in April 2019.
Y-m Abs Neuroblastoma Innovative Therapy Applied for Listing
Time of Update: 2020-06-01
Neuroblastoma is one of the most common cancers in infants and young children. It is a highly invasive tumor, and even with highly potent treatments, the patient's survival rate is less than 50%. Naxitamab is a humanoid monoclonal antibody